About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.
CLEVELAND — Two Northeast Ohio moms are on a mission to create a community for mothers. "The Village" started with its two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback